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From the Director
The theme of our newsletter this fall is transitions. In this issue we highlight
our new faculty hire, Professor Natalie Ram, and the new Law & Health
Care Program Managing Director Rebecca Hall. As we welcome these new
members to our health law community we also say goodbye to two longtime faculty members who retired over the summer – Karen Rothenberg,
founder and first director of the L&HCP, and Deb Weimer, director of the
first law school AIDS clinic in the country. We also bid farewell to Lauren
Levy, former managing director of the program who left to become the
health officer for Cecil County, MD. —Diane Hoffmann, Director

Professor Natalie Ram Joins
Law & Health Care Program

T

his semester, the Law & Health Care Program (L&HCP) welcomed its
newest faculty member, Natalie Ram. Professor Ram’s work is at the
intersection of innovative biotechnology and the law. A Greenwall Faculty
Scholar in Bioethics, Ram is a leading expert on genetic privacy and the
law, publishing groundbreaking research in Harvard Law Review, Stanford
Law Review, Columbia Law Review, Northwestern Law Review and Iowa
Law Review, among others.
“We are very excited to have Natalie join our faculty,” said the program’s
director Diane Hoffmann. “Her scholarship on the use of consumer genetic
databases for law enforcement purposes raises profound privacy issues for
individuals and families. Her work is at the cutting edge of health law and
criminal law and has significant policy implications.”
Most recently, she has gained national recognition for her work on issues
related to law enforcement access to consumer genetic databases like
23andMe, GEDmatch, and other DNA repositories. Continued on next page.
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“It’s really important to make clear
the stakes that are involved when law
enforcement can exploit genetic data
in new ways,” says Ram. “We should
carefully consider those stakes before
we rubber stamp these new kinds of
forensic methods and then find that
we’ve sacrificed a whole lot of privacy
that we did not intend to sacrifice.”

also has written several op-eds for
Slate and published articles in the
scientific journals Science and Nature
Biotechnology. In her most recent
article for Slate, Professor Ram
continues her important contributions
to the evolving dialogue surrounding
issues of innovative DNA technology
and resulting privacy concerns.

Professor Ram has written about
recent site policy changes at the
online genealogy website that law
enforcement has recently begun to
use to conduct a “forensic technique
known as genetic genealogy: a
method in which investigators
try to link crime scene DNA to
DNA from biological relatives in
the hopes of generating leads for
identifying suspects or remains.”
Most famously, law enforcement
pursued genetic genealogy to
apprehend the man alleged to be the
Golden State Killer, a moniker for
a criminal supposedly responsible
for more than 150 violent crimes in
California between 1974 and 1986.
Reflecting on this new means of
solving crimes, Professor Ram raises
important legal and ethical concerns
about the constitutionality of such
techniques and “the risks of putting
so much decision-making power in
the hands of a private entity.”

Ram also is a leading voice in
Maryland’s conversation around state

Since investigators cracked the
decades-old Golden State Killer case
in 2018 using familial identification
DNA evidence obtained from
GEDmatch, Ram has been consulted
regularly by national media outlets.
She has appeared on CNN, national
radio broadcasts “Science Friday” and
“Here & Now,” and been quoted in
the Wall Street Journal, Washington
Post, and BuzzFeed News. She

regulations on law enforcement access
to genetic databases. Last year, she
published an article in the Maryland
Bar Journal and was invited by a
member of the Maryland House of
Delegates to testify in Annapolis in
support of a bill prohibiting familial
searching in DNA databases.

“

I am excited about
the possibilities that
joining this program,
the law school, and
the University of
Maryland—with its
excellent medical
school as well—will
bring for my research
and teaching.”
Natalie Ram
Associate Professor of Law

As a former law clerk for Judge
Guido Calabresi of the U.S. Court of

Professor Natalie Ram Joins Law & Health Care
Program, cont.
Appeals for the Second Circuit and
then for Justice Stephen G. Breyer of
the U.S. Supreme Court, Professor
Ram also has a particularly wellinformed perspective on the criminal
law implications of the use of such
technology by law enforcement.
In an interview with PBS, she
discussed the 2018 Supreme Court
decision in Carpenter v. United
States, which held that warrantless
searches of cellphone location data
are unconstitutional invasions of
reasonable expectations of privacy.
She noted that “this ruling is likely
to apply more broadly to deeply
sensitive information shared with a
third party, such as genetic data.”
Ram has expanded upon this topic
in numerous scholarly works and
presentations, including her most
recent article on the subject, “Genetic
Privacy After Carpenter,” and her
presentation on “(In)voluntariness in
Forensic Genealogy” at the Harvard
Law School’s Consuming Genetics
conference in the spring of 2019.
In addition to her significant
scholarly contributions to the field
of bioethics and privacy, Professor
Ram also brings her thorough
and energetic teaching style to
Maryland law students. Her teaching
interests include bioethics, property,
intellectual property, civil procedure,
and criminal procedure.

in Washington, D.C. prior to her work
as an assistant professor of law at the
University of Baltimore School of Law.

Professor Ram studied public and
international affairs at the Woodrow
Wilson School at Princeton
University before receiving a JD from
Yale Law School. After completing
her clerkships on the U.S. Court of
Appeals and the U.S. Supreme Court,
Professor Ram practiced law at a firm

Professor Ram is excited and delighted
to join the University of Maryland
Francis King Carey School of Law,
and in particular about joining the
excellent faculty in the Law & Health
Care Program. “The Law & Health
Care Program is well-established and
widely-respected, and I am thrilled

Professor Natalie Ram

to count myself among its faculty. I
am excited about the possibilities that
joining this program, the law school,
and the University of Maryland—
with its excellent medical school as
well—will bring for my research and
teaching.” ■
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Professor Diane Hoffmann and CoInvestigators Awarded $1.1M NIH Grant

I

n August, Professor Diane
Hoffmann and an interdisciplinary
team of co-investigators from the
University of Maryland Baltimore
(UMB) were awarded a $1.1 million
grant from the National Institutes
of Health’s (NIH) National Human
Genome Research Institute for
their project “Microbiome-Based
Diagnostics: Stakeholder Perceptions
and Implications for the Regulatory
Framework.” The team will study
the appropriateness and adequacy
of current regulatory frameworks
for microbiome-based diagnostic
tests and develop comprehensive
recommendations for improvement.
This is the third NIH grant Professor
Hoffmannn, who is the principal
investigator (PI), and a number of her
current coinvestigators, have received
to address regulatory issues associated
with new microbiome-based therapies
and diagnostics. The first award was to
explore regulatory issues for probiotics
sold as food and dietary supplements,
while their second grant focused
on the regulation of microbiota
transplants.
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Microbiome research has led to
promises of using the bacteria in
an individual’s gut to diagnose
or predict everything from that
individual’s propensity for obesity
to their mental health, sometimes
through at-home testing kits. While
much of the research in this area
has focused on infectious disease
diagnostics, more recent development
has focused on tests to identify
microbial characteristics or risk factors
associated with non-communicable
chronic diseases. There are now
several commercially available
microbiome-based personalized tests.
Companies like Viome, DayTwo,
uBiome, and Thryve have sold
or are selling direct-to-consumer
tests claiming to tell you what
your microbiome looks like, how
it compares to that of others, and
what foods you should eat or dietary
supplements you should take. These
are not “diagnostic” tests, but more
like informational or recreational tests,
although some companies also try to
sell you probiotics that “match up”
with your microbiome profile. There
are, however, numerous companies

with diagnostics in various stages
of development that will be able to
identify biomarkers for cancer. Some
of these tests must be ordered by a
physician while others are direct-toconsumer or are contained within
“citizen science” projects that provide
individuals with information on the
composition of their microbiome
if they consent to the use of their
biological samples in research studies.
The new tests raise new ethical
concerns that are similar to those
raised in the early days of genetic
testing – appropriate communication
of test results, concerns about clinical
validity and utility (particularly with
regard to direct-to-consumer tests),
informed consent, privacy and the
potential for discrimination and
stigma. The Genetic Information
Nondiscrimination Act (GINA) of
2008 was passed amid growing
concern that information gleaned from
genetic testing could result in the
stigmatization or discrimination by
employers and health insurers against
individuals with particular health
conditions. Could microbiome-based

Professor Diane Hoffmann and Co-Investigators
Awarded $1.1M NIH Grant, cont.
diagnostics present a similar risk of
stigma and discrimination? If so, will
GINA apply to microbiome-based
tests?
Other concerns include the
potential use of the tests to predict
predisposition for disease based
on microbial composition without
offering any clinical utility. Or, the
possibility that the test could uncover
disease status or risk as an incidental
or secondary finding. For direct-toconsumer products, there is a risk
that consumers will be misled by
claims that are not supported by
the research in addition to the risks
associated with providing results to
individuals who lack the expertise to
understand them. Others have argued
that providers ordering these tests
may have insufficient expertise to
interpret results and rely too heavily
on the expertise of the commercial
laboratories that sell the tests. In

the context of “citizen science”
initiatives, there are research ethics
concerns particularly with regard to
informed consent and the extent to
which participants understand the
downstream implications of providing
biological samples particularly when
many risks are as yet unknown.
The UMB team will utilize the
expertise and resources of the Schools
of Law, Nursing, Pharmacy, and
Medicine and their proximity to the
University of Maryland Medical
Center to take a close look at the
implications of this new field of
diagnostics. The microbiome project
will evaluate the existing legal and
regulatory frameworks that apply
to these new products and their
use and assess patient and provider
perspectives on their value, utility, and
potential for misuse in order to inform
future regulatory approaches for these
tools and ensure their appropriate

use in patients. The overall goal of
the project is to inform and support
policy and regulatory approaches
that stimulate scientific discovery,
identify and address problems or gaps
in the current regulatory and legal
framework, and encourage innovation
while ensuring new microbiome-based
products are safe and effective. ■

“Microbiome-Based Diagnostics: Stakeholder Perceptions and Implications for the Regulatory Framework.”
University of Maryland, Baltimore Co-Investigators
Professor Diane Hoffmann (PI)
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Karen Rothenberg: A Legacy of Innovation
and Passion

Professors Diane Hoffmann and Karen Rothenberg

This article is an excerpt from a
larger piece by Diane Hoffmann
written for the forthcoming issue
of the Journal of Health Care Law
and Policy devoted to the legacy of
Professor Karen Rothenberg.

K

aren Rothenberg, the Marjorie
Cook Professor Emeritus of Law,
retired this summer after 36 years of
teaching at the law school. Professor
Rothenberg’s decades long career
as a health law scholar, teacher, and
mentor includes, among her many
other impressive achievements, being
the founding director of the Law &
Health Care Program (L&HCP) and
a former dean of the University of
Maryland School of Law.
I write this article for the newsletter as
someone who was mentored by Karen,
who has benefited from her wisdom
Pg 6

and advocacy, who has collaborated
with her on policy initiatives, coauthored articles with her, worked
for her as associate dean, co-taught
courses with her, and who has been her
colleague and friend for over 30 years.
A Career in Three Parts
Part 1
Karen started at the law school in
1983, just a few years before me, and
her plan was to develop and grow a
law and health care program. She was
prescient about the field of health law.
After graduating from law school at
the University of Virginia, she worked
for the law firm of Covington &
Burling, in Washington, D.C. where
Charles Miller was her mentor. On
reflecting on her time at the firm,
Miller said:
“I always knew that Karen was
destined to be a leader in health law

when she joined our firm in 1979 and
told me she wanted to develop a health
law practice before we knew there was
such a field as health law. Karen had
the vision to see that we were then on
the brink of a great development in
this field, and the energy to convert
that vision into reality. Her decision
to join the University of Maryland
faculty and head up the Law &
Health Care Program when no one
could have told you what such a
program really would or should
entail further illustrates that she was
a true pioneer and destined for great
accomplishments.”
In large part, I was hired to help
Karen build the L&HCP. For the
next dozen years, we worked closely
together as colleagues developing the
program, teaching and working on our
scholarship. As an assistant professor,

Karen Rothenberg: A Legacy of Innovation and
Passion, cont.
Karen was incredibly prolific and,
it seemed to me when I arrived, had
already made a name for herself in the
health law and policy academy. In the
first four years of her professorship
she had been a legal consultant for the
American College of Nurse-Midwives,
served on a National Institutes of
Health (NIH) consensus panel on the
use of diagnostic ultrasound imaging
in pregnancy, and led a task force to
plan a forum held by the NIH and the
International Childbirth Education
Association on Medical Malpractice
Issues in Obstetrics.
During the next eight years she served
on numerous boards, advisory and
planning committees, and as an officer
or leader in a number of health law
organizations. These positions included
the Board of Directors of the National
Health Law Program, chair of the
Association of American Law Schools’
section on Law, Medicine & Health
Care, and member of the Institute of
Medicine’s Committee on Legal and
Ethical Issues Relating to the Inclusion
of Women in Clinical Studies.
Early on in her career, Karen
developed a relationship with a
number of researchers and policy
makers at the NIH and spent several
sabbaticals and leaves (under the
Intergovernmental Personnel Act) at
different institutes there. The first was
in the spring of 1991 when she worked
at the National Institute for Child
Health and Human Development. In
the course of her work there, she met
Elizabeth Thompson and became very
interested in newly available prenatal
genetic tests and the profound issues
they raised for pregnant women. This
experience was to be the foundation
for much of her early and long-term
scholarship. During this time, Karen

was focused primarily on women’s
health and reproductive issues and
women in clinical trials. With the
coming of the genetic revolution,
Karen became embroiled in the world
of prenatal genetic testing, co-editing
her first book with Elizabeth Thomson
on that topic. It was this work that led
to what has become the scholarship for
which she is most well-known: legal
issues in research and clinical practice
involving genetic testing and treatment.
From September of 1995 until May
of 1996 Karen spent the academic

“

I always knew that Karen
was destined to be a
leader in health law when
she joined our firm in 1979
and told me she wanted
to develop a health law
practice before we knew
there was such a field as
health law.”

Charles Miller
Covington & Burling
year at the NIH’s Office of Research
on Women’s Heath as a special
assistant to the director, Vivian Pinn.
There she continued her work on the
inclusion of women in clinical trials
and expanded her scholarship on
genetic issues. From 1995 to 1999,
she published numerous articles on
such topics as genetic discrimination
and health insurance, the challenge of
too much genetic information, genetic
information and the workplace, cancer
genetic susceptibility testing, privacy
in genetics research, and cloning.

During this time, she also developed
and honed certain positions on
significant ethical issues created by
genetic testing and genetic research.
These included the idea that not all
medical/genetic information is a
good thing. This idea ran counter
to the general medical view at the
time that more information is better.
However, Karen persuasively argued
in a number of forums that sometimes
people might not want to know that
they are likely to develop a certain
disease or disabling condition such
as Huntington’s or Alzheimer’s,
particularly when there is no cure for
the disease. Karen also had strong
concerns about discrimination based
on the results of genetic testing and
published several articles in the
prestigious journal, Science, about the
potential use of genetic test results
by health insurers to deny individuals
insurance and by employers who
might choose not to hire someone
with a predisposition to a serious
genetic disease.
Part 2
Karen’s concerns about the use of
genetic test results to discriminate
led her to help to lay the groundwork
for legislation at the federal and
state levels that would prohibit the
use of such test results by insurers
and employers. But her work on this
important legislation was put on hold
momentarily as she took over as
interim dean (1999–2000) and then
dean (2000–2009) of the law school.
During this time Karen kept up her
work on legal and policy issues arising
out of the developments in genetics.
In particular, she continued her
advocacy for the Genetic Information
Nondiscrimination Act (GINA), which
was ultimately passed by Congress in
Continued on next page.
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Karen Rothenberg: A legacy of Innovation and
Passion, cont.
2008, and worked with members of
the Maryland General Assembly to
pass similar legislation in Maryland.
While serving as dean, Karen
somehow also managed not only to
sit on the newly established Maryland
Stem Cell Commission, but also
to chair it – a time consuming and
demanding job. It was a significant
role which required establishing all the
procedures, protocols, and policies by
which the commission would allocate
a several million-dollar budget to
Maryland scientists performing stem
cell research. Jack Schwartz, who
sat on the Stem Cell Commission
at the time Karen served as chair,
wrote in a tribute to Karen about the
controversy that enshrouded the effort
to establish a stem cell commission
in California but reported that “Karen
had the discernment to know that the
best path forward for the Maryland
effort would be . . . quiet and steadfast
professionalism – a scientifically sound
grant review process, free of conflicts
of interest and political agendas.”

alone may not allow. Professor Frank
Pasquale commented about how
“Karen’s turn to literature recognizes
that our plays and poems, stories and
films, reveal patterns of power and
meaning in the world by exploring the
ramifications of critical relationships.
They illuminate fundamental aspects
of human experience.” While Karen
explored the depths of existing
literature to illustrate aspects of the
human condition affected by science,
she was not content to simply analyze
the writings of others. In addition,
she co-authored several original plays
designed specifically to examine
some of the intractable dilemmas
that current genetics research and
clinical practice raise. Often enlisting
colleagues to play the actors in her
theatrical productions, Karen used
these plays as a way to generate
conversations between scientists,
bioethicists and health law academics
and to help researchers understand the
difficult decisions patients must make
as a result of new genetic information
and technologies.

Professor Michael Ulrich, a former
student in this innovative class, says
he felt empowered as a student to
have the opportunity to work with
these genetic experts on cutting edge
genetic policy issues. He is just one of
the many students Karen empowered
and inspired in her years of teaching
health law.

Part 3
In the last phase of her career, after
stepping down as dean, Karen married
her love of theater with her passion
for the ethical, legal, and social issues
arising out of research and clinical
practice related to genetics and
devoted much of her scholarship to
the use of plays to explore and mine
those issues. She has written articles
about plays that many of us have read
or seen performed examining the
scientific and ethical questions they
raise, often foreshadowing some of
the current dilemmas we face as a
society in whether and how to regulate
science. But she also sees plays as
vehicles for examining relationships
in ways that the study of science

Also, in this phase of her career, Karen
spent several years at the NIH as
senior advisor to Eric Green, director
of the National Human Genome
Research Institute (NHGRI) and at
the Clinical Center working with Ben
Berkman and others. While there
Karen developed “the idea for an
intensive workshop where students
would research and analyze a range
of ethical, legal and policy questions
raised by the increasing prevalence
of human genome sequencing in
research.” Karen called on several
colleagues at the NIH to serve as
supervisors for law students in a nontraditional law school course that was
part externship, part seminar and part
clinic. In another tribute to Karen,

3. Genetic Information Nondiscrimination Act of
2008, 42 U.S.C. § 300gg-53 (2008).
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Conclusion
As Karen’s colleague for the last 32
years I have truly been fortunate. I
have been touched by her generosity,
creativity, encouragement and
friendship. The latter is something I
treasure and hope will continue for
many years to come. ■
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Professor Deborah Weimer, Founder of the First
Legal Clinic for Persons with HIV/AIDS, Retires

P

rofessor Deborah Weimer started
teaching at the University of
Maryland School of Law in 1988.
She grew up on Long Island and
put herself through college at State
University of New York, as the first
member of her immediate family to
attend college, with a combination
of jobs, scholarships, and loans. She
attended law school at New York
University during an exciting time.
NYU law faculty and students were
deeply involved in the civil rights
movement, as well as the antiwar
movement, and she worked with
other students to create the New
York University Public Interest Law
Foundation, which funded public
interest placements for lawyers, before
graduating in 1978.
Although Professor Weimer began
her legal career with New York City’s
largest municipal public employee
union, she soon was awarded a grant
by the NYU Foundation to provide
legal assistance to disabled textile
workers through the Brown Lung
Legal Center in Columbia, South
Carolina. There she trained lawyers
handling workers’ compensation
cases and worked hard to increase
occupational safety protections and
to make the workers’ compensation
system more responsive.
In 1982, Professor Weimer joined the
Palmetto Legal Services Program in
Columbia, South Carolina, adding
an employment law specialty to her
practice. She litigated in federal
and state courts, including wrongful
discharge and Fair Labor Standard
Act cases, and also handled a “general
practice” legal services caseload,
all while also chairing a statewide
Employment Law Task Force. Early
in her career, she was developing

the multi-tasking skills
that she has used all her
professional life.
In 1985, Professor
Weimer began a two-year
Fellowship at Temple
University School of Law,
where she collaborated
in teaching Civil Trial
Advocacy, Bankruptcy,
Property, and the
Lawyering Process, which
included brief writing and
oral advocacy. There, she
earned her LLM in Legal
Education.
In 1987, she moved to
Maryland and worked for
seven months in a civil
rights firm with LGBT
clients before being
hired at Maryland on a
Department of Education
grant to establish a medical-legal
partnership at the Pediatrics clinic
at what is now the University of
Maryland Medical Center (UMMC).
This was one of the earliest legalmedical clinical partnerships in the
country. Professor Weimer quickly
expanded it to create one of the first, if
not the first, law school clinics in the
country serving patients with acquired
immune deficiency syndrome (AIDS).
When the three-year Department of
Education grant ended, the Maryland
Legal Services Corporation stepped
in and has continued to fund it in
significant part for almost 30 years.
Because, especially in the 1980s
and 1990s, AIDS was such a fatal
disease, the focus of Professor
Weimer’s clinics and Legal Theory
& Practice courses included not only
clients who had tested positive for

Professor Deborah Weimer

human immunodeficiency virus (HIV),
but also the children of those clients,
including some children who were
also HIV-positive, and grandparents
of those children who had to assume
parental responsibilities. These clinics
have always had interdisciplinary
components, and in one, a research
component. One that focused on
grandparent families included a formal
study to test the effectiveness of the
interdisciplinary approach, which
Professor Weimer describes, because
of this holistic approach, as one of her
“most rewarding clinics.” This was a
partnership with the Schools of Social
Work and Nursing.
Professor Weimer’s scholarship has
grown out of her practice. She has
been one of the leading scholarly
Continued on next page.
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Professor Deborah Weimer, Founder of the First Legal
Clinic for Persons with HIV/AIDS, Retires, cont.
voices, in Maryland and nationally, on
Standby Guardianship and Foster Care
issues for HIV-infected children or the
surviving children of parents who died
of AIDS, among other topics.
She has received a number of
awards for her extraordinary work,
including the Maryland Legal Services
Corporation’s Benjamin L. Cardin
Distinguished Service Award, the
University of Maryland Community
Service Award, and the Maryland Bar
Foundation’s Award for Professional
Legal Excellence in the Advancement
of Unpopular Causes. The National
Jurist Magazine also recognized her
AIDS Clinic in a national survey titled
“Law Clinics that Make a Difference.”
Her work also includes a voluminous
amount of presentations, many on
interdisciplinary panels, to a wide
variety of audiences.
It is daunting, if not impossible, to
summarize her legacy, but several
central themes emerge.
1. Combining Legal Leadership
in the Field and an Extraordinary
Education for her Students
Professor Weimer and her students
became the legal leaders in Maryland,
and early-on nationally, in the legal
battle against AIDS and its tragic
consequences. Today, our clinic retains
that important role. With the advances
of medicine, it is focusing on the legal
obstacles people living with HIV
face in getting life-saving medical
care, like health insurance, stable and
safe housing (i.e., no mold or lead
paint), protection from employment
discrimination, and SSDI benefits.
Many of her former students, now
lawyers practicing throughout
Maryland and beyond, have said that
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their participation in her clinic was
the critically important experience in
persuading them to embark on legal
services and public interest careers or
to do substantial amounts of pro bono
work in their private practices.
2. Being a Reformer
From 1988 to 1995, Professor Weimer
was a member of an interdisciplinary
legislative advocacy committee that
proposed and supported reforms in
Annapolis. From 1993 to 1994 alone,
she and her students played key roles
in drafting and supporting Maryland’s
Standby Guardianship Act, which
allows a person facing death to provide
for loved ones (for example, by
avoiding the unnecessary placement of
children in foster care), and Maryland’s
Needle Exchange Pilot Program in
Baltimore City, for which they drafted
the legislation as a way to prevent
the spread of HIV. They also won
important court decisions, including
those proscribing discrimination
based on one’s medical condition and
requiring informed consent for medical
testing and treatment.
3. Exemplifying Leadership and
Partnership in the UMB Community
The list of Professor Weimer’s UMB
partnerships is long. It includes not
only the initial pediatrics project with
UMMC, but also the Social Work and
Nursing Schools’ grandparents’ project
and the formation of many informal
relationships among doctors and
medical students, nurses and nursing
students, social workers and social
work students, and Professor Weimer
and her law students. These have
brought to life one of the purposes
of a multi-graduate school campus
to engage the disciplines in working
with each other, which, in turn, helped

make Maryland Carey Law’s Health
Law and Clinical Law programs
among the best in the country.
4. Introducing Students to the
General Practice of Law
Professor Weimer’s clinics have also
introduced students to the types of
general law practices that sustain
solo and small firms, where many
Maryland students may end up.
This has been an important, often
overlooked benefit, that AIDS clinic
alumni have emphasized. There is
no specialized body of “AIDS law.”
Rather, the practice includes many
subject matter practices: access to
health care, housing, family law,
benefits, guardianships, wills, antidiscrimination laws, and more, all of
which are integral parts of the AIDS
clinic practice.
5. Demonstrating Willingness to
Take on New Challenges
The willingness to take on new
challenges has been a hallmark
of Professor Weimer’s career,
demonstrated most recently by her
creation of a new Legal Theory
& Practice course. Creatively, it
combines property and health law
issues, including the remediation
of mold and lead paint, while also
focusing on professional responsibility
issues, specifically the misbehaviors
of lawyers who oppose unrepresented
parties. Students provide legal
representation to tenants and
write a semester paper about their
experiences. She describes this course
in a 2017 article in the Hastings and
Poverty Law Journal, “Deepening
Lawyer Role Education to Serve
Students and Society.”

Professor Deborah Weimer, Founder of the First Legal
Clinic for Persons with HIV/AIDS, Retires, cont.
6. Modeling the Qualities of a Good
Lawyer
Above and beyond all of her
other remarkable achievements,
Professor Weimer remains a model
of an extraordinary lawyer. She
is committed to her clients, often
working seven days a week, 52 weeks
a year, and sometimes in 24-hour work
days, to meet her commitments.

creativity and willingness to expand
and diversify her practices and courses
to meet unmet legal and educational
needs. Through it all, she maintains
an extremely high standard of
professionalism while being a powerful
advocate, and remains a superb
example not only for her students,
but also for her colleagues and every
member of the legal profession.

She always pays careful attention
to ethical issues and demonstrates
that ethical behavior is an essential
part of law practice. She displays a

Though she will be greatly missed by
the law school community, Professor
Weimer’s legacy will undoubtedly
continue on through the Medical-

Legal Partnership Clinic she created,
as well as the impact she has had on
so many former students, clients, and
colleagues. Her impact on the Law &
Health Care Program, law school, and
state of Maryland will be felt for years
to come. ■
Adapted from a tribute by Professor
Michael Millemann.

Visiting Professor Matiangai Sirleaf Brings
a Global Perspective to Maryland Carey Law

T

he Law & Health Care Program welcomes Professor
Matiangai Sirleaf, who is a visiting associate professor of law
for the 2019 fall semester. Professor Sirleaf brings her extensive
scholarly expertise and practical experience in Global Public
Health Law, International Human Rights and Criminal Law,
and Post-Conflict and Transitional Justice, to the law school.
She is currently an assistant professor of law at the University
of Pittsburgh Law School, where she received the Chancellor’s
Distinguished Research Award in 2019. Her work focuses
on remedying the accountability and responsibility gaps that
exist in international law. Her current research focuses on the
disproportionate distribution of highly-infectious diseases and
the role of law in facilitating this result. Professor Sirleaf was
also recently awarded a Social Science Research Initiative grant
for her proposal, “Understanding the Development and Impact
of Neglected Tropical Diseases (NTDs) – 1950 to Present.”
In addition, she was selected to present her paper “Disposable
Bodies and Experimental Trials” at the 2019 Health Law Scholars
Workshop jointly sponsored by St. Louis University School of
Law and the American Society of Law, Medicine & Ethics. ■

Visiting Professor Matiangai Sirleaf
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Law & Health Care Program Welcomes New
Managing Director Rebecca Hall
The Law & Health Care
Program is pleased
to announce the
appointment of Rebecca
Hall as its new managing
director. Hall is a 2013
graduate of Maryland
Carey Law and the health
law certificate program,
and has practiced health
law in the Baltimore
and DC area since graduation, first representing
the University of Maryland Faculty Physicians in
downtown Baltimore and, most recently, splitting
her time between Rockville and Hunt Valley as senior
associate counsel for the nation’s leading network
of pain management practices. She also draws on
her experience prior to and during law school, which
includes work for UnitedHealth Group, the Medicaid
Fraud Control Unit of the Maryland Office of the
Attorney General, the Court of Special Appeals of
Maryland, and the Maryland General Assembly.
During her time as a health law student, Hall
participated in numerous health law competitions,
including the inaugural Health Law Regulatory &
Compliance Competition, and led the Journal of
Health Care Law & Policy as its editor in chief. Since
graduating, Hall has remained involved in the program
as a repeat judge of the Regulatory & Compliance
Competition, student mentor, competition team
advisor, and internship supervisor. Hall is thrilled to
return to the Health Law Program at this exciting
time. On starting the job she remarked: “Having
been involved in almost every aspect of the program
as a student, alumnus, and mentor, I am extremely
excited to return to the law school in this capacity
to encourage the next generation of health lawyers
while continuing to build on the program’s excellent
reputation for producing outstanding scholarship
and exemplary practitioners. I look forward to
getting to know each and every health law student
and to engaging with our extensive alumni network
to continue the program’s leadership in health law
education and scholarship in my hometown of
Baltimore and nationwide.”
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Lauren Levy Leads Cecil
County Health Office
In May, Lauren Levy, former managing
director of the Law & Health Care Program, was
appointed health officer for the Cecil County Health
Department. Levy worked closely with Program
Director Diane Hoffmann from July 2017 until May
2019, overseeing the program’s externships and
nurturing the Law & Health Care Program. The
health officer position marks a return of sorts for
Levy, who worked in public health research and
program management for many years before
returning to school to complete her law degree as
an evening student. In her new role, Levy serves as
the executive officer for the agency, which employs
140 staff across six divisions.
“It has been a steep learning curve,” Levy said. “The
health department is involved in a diverse range
of activities – from treatment for substance use
disorder to STD testing to diabetes prevention and
environmental health, among many others. I have
learned a lot in just a few short months.”
Levy credits her training through the Law & Health
Care Program with helping her to navigate the new
role. “Having the grounding in health law and policy
has been invaluable. I am relying on the research
and analytical skills I developed as a student in the
health law program on a daily basis.”
Levy is excited to stay involved with the health law
program as a member of the policy committee of
the Maryland Association of County Health Officers,
a group that works closely with the Legal Resource
Center for Public Health Policy, led by Professor
Kathi Hoke. “It was a difficult decision to leave
the Law & Health Care Program. I am so glad to
have the opportunity to continue working with the
program’s stellar
faculty, staff
and students to
develop policy
approaches to
address our
most pressing
public health
challenges.”

Pain & the Law: Professor Diane Hoffmann Shares
Expertise with Audiences from Coast to Coast

P

rofessor Diane Hoffmann,
director of the Law & Health
Care Program and Jacob A. France
Professor of Health Care Law at the
University of Maryland Francis King
Carey School of Law, has written
and spoken extensively about legal
obstacles to, and gender disparity
in, the treatment of pain. Over the
summer, she shared her expertise on
these topics in several fora.
On June 19, 2019, the University of
Maryland, Baltimore (UMB) held
a forum to share the work being
conducted across disciplines on
campus to better understand, treat,
and modify the impact of chronic
pain. Held in Baltimore, the event
was moderated by Joel Greenberg,
co-director of the University of
Maryland Center to Advance Chronic
Pain Research (CACPR). Professor
Hoffmann was one of four expert
panelists. Also presenting were Luana
Colloca, associate professor at the
University of Maryland School of
Nursing and associate professor at
the University of Maryland School
of Medicine (UMSOM); Marcela
Romero-Reyes, clinical associate
professor at University of Maryland
School of Dentistry (UMSOD) and
clinical director of its Brotman Facial
Pain Clinic; and Asaf Keller, professor
at UMSOM. All are members of
CACPR, and Hoffmann and Keller
are on its executive committee. The
multidisciplinary center is composed
of nationally and internationally
renowned clinical and preclinical
translational scientists. The principal
research focus of CACPR members
is on the physiological, genetic,
and psychosocial underpinnings of
the development and persistence of
debilitating chronic pain conditions.

Greenspan, professor and chair of the
UMSOD Department of Neural and
Pain Sciences, characterized chronic
pain as a high-impact, complex
problem affecting the quality of life of
millions of U.S. residents who are kept
from doing the things they need or
want to do. “We’ve got a wide swath
of talent,” he said, referring to UMB’s
top-tier scientists and clinicians,
adding that such breadth is needed to
continue making progress.
Hoffmann spoke about the current
state of chronic pain in the aftermath
of the opioid epidemic and the
crackdown by law enforcement
on physicians prescribing large
volumes of opioids. This in turn has
frightened physicians, causing many
to “stop seeing chronic pain patients

or tapering them off of opioids
involuntarily, literally abandoning
them,” she said. “In some cases, such
abrupt removal of opioid treatment
has led to suicides,” she added. This
kind of abandonment can be grounds
for malpractice or action by state
medical boards. Hoffmann attributed
the situation in part to the actions
of over half of state legislatures to
codify specific dosage and duration
limits for opioid prescribers based
on a prescribing guideline issued
in 2016 by the Centers for Disease
Control and Prevention (CDC). The
guideline, however, was intended as a
discretionary suggestion for primary
care providers not as a mandatory rule.
In response, last December, Hoffmann
and colleagues published an article
in STAT, “Overzealous use of the

Professor Diane Hoffmann presenting at the CACPR’s June 19 Forum
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Pain & the Law: Professor Diane Hoffmann Shares
Expertise with Audiences from Coast to Coast, cont.
CDC’s opioid prescribing guideline
is harming pain patients,” about the
situation and she and other paintreatment advocates urged adoption
of more compassionate tapering,
among other things. However, in
April, she noted, authors of the CDC
guideline, alarmed by reports of its
misuse, published a commentary in a
prominent medical journal advising
against its misapplication, which, they
acknowledged, can risk patient health
and safety. “I’m hopeful this is a first
step in efforts to rectify overzealous
application of the CDC guideline,” she
told the group.
Panelist Asaf Keller, from the School
of Medicine, described an initiative of
the University of Maryland Strategic
Partnership: MPowering the State
that supports both professionals in the
field and university students across
disciplines. “Clearly what is needed is
a much more rational approach to pain
management in general and to opioid
prescription in particular. We are
addressing this issue at all the schools
on campus,” he said, describing ways
of imparting knowledge necessary to
apply this rational approach. Keller
also outlined other efforts such as a
“cuddling” initiative to help babies
who are in misery after being born
with neonatal opioid abstinence
syndrome. These infants, born to
mothers who used opioids during
pregnancy, fare better if provided skinto-skin contact. “It’s very low cost,
very low-tech,” he said.
Romero-Reyes, a researcher and
clinician at the Dental School, said
her focus is to provide evidence-based
pain management for facial pain. Such
pain can have multiple causes. “As
a clinician, I have the opportunity to
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see firsthand the needs of this patient
population,” she said. “As a scientist,
I’m able to translate those needs to
research questions,” such as current
studies on overcoming neuropathic
pain.
Colloca, a faculty member at the
School of Nursing, asked the group,
“How can we better manage pain?”
Demand is great for solutions beyond
opioids, and a patient’s own mindset
could be part of the solution. Colloca
suggested that patients be asked
to describe their pain levels not as
a number, ascending from mild to
severe, but rather as a ranking of
everyday activities they can do.
She also proposed thinking about
approaches to help people increase
their tolerance of pain, perhaps by
stimulating the brain to produce
natural substances that combat pain
messages or by distractions such as a
virtual reality.
At the outset of the forum, guests at
the event had a chance to try a virtual
reality simulation used by Colloca in
her research, as a potential distraction
to pain. Several took part in a
demonstration in which a headset took
each individual to an undersea setting
where a whale loomed overhead.
Members of Colloca’s lab were eager
to show off its research, which is also
supported by MPowering the State.
During a question-and-answer session
to conclude the event, guests shared
observations and problems of their
own or of family members who
struggle with chronic pain. Patient
Dante Wheatley was accompanied
by his mother, dental assistant Kim
Jones, and by her employer, Willie
Richardson, DDS, who all spoke of

how chronic, high-impact pain has
affected Wheatley’s daily life.
Hoffmann also spoke at several other
events related to chronic pain over
the summer. In July, she spoke at the
Healthy Women Science, Innovation &
Technology Summit on Chronic Pain
in Women, focusing her remarks on
disparities in the treatment of women
for chronic pain. On August 14th,
Hoffmann traveled to Sacramento,
California where she participated in
a legislative briefing on chronic pain.
Hoffmann, along with other pain
experts including Sean Mackey, chief
of the Division of Pain Management
at Stanford University, Christin
Veasley, director of the Chronic
Pain Research Alliance, and Steven
Richeimer, chief of Pain Medicine,
University of Southern California,
urged the California legislature to
adopt several recommendations to
improve chronic pain treatment.
Hoffmann and these experts developed
the recommendations as part of a
California Pain Summit, held last
November in Los Angeles by For
Grace, a non-profit organization
that advocates for better care and
treatment of women with chronic pain.
Hoffmann is on the Board of
For Grace. ■

The Public Health Law Clinic and Network for
Public Health Law Continue to Influence State
Policy on Cannabis Regulation

I

n 2014, the Maryland General
is detrimental to public health. The
Hoke’s guidance, clinic students
Assembly passed legislation
provisions in these bills were absorbed
have advocated for key cannabis
permitting the use of cannabis for
legislation in Annapolis. This past
into a larger medical cannabis bill,
certain medical conditions and
Maryland House Bill 17/Senate Bill
session, clinic student John Travers
the creation of a medical cannabis
857, which passed in the State Senate
’19 testified in support of legislation
industry, from growers to distributors. that would have authorized institutions and the House of Representatives.
The state’s medical cannabis system,
Governor Larry Hogan signed the
of higher education and related
which allows patients with qualifying
medical facilities, like the University
legislation in April and it went into
conditions certified by an authorized
effect on July 1.
of Maryland, Baltimore (UMB), to
health care provider to
acquire cannabis from
In addition to her work
licensed dispensaries,
with the Public Health Law
opened for business in
Clinic, Professor Hoke is
December 2017. Medical
the executive director of the
cannabis in Maryland has
Network for Public Health
generated a whirlwind of
Law’s Eastern Region.
legal, public health, and
The Network for Public
social justice issues, not the
Health Law is a national
least of which is the fact
organization funded by
that cannabis (marijuana) is
the Robert Wood Johnson
still defined by the federal
Foundation. The network’s
government as a “Schedule
Eastern Region is housed in
I drug,” “with no currently
the law school. The network
accepted medical use and
provides legal assistance on
a high potential for abuse”
a broad spectrum of public
under the Controlled
health issues, including
Substances Act, making it
the regulation of cannabis.
illegal under federal law
Eastern Region Associate
to use, even for medicinal
Director Mathew Swinburne
purposes. The University
’08 is the network’s expert
of Maryland Francis King
on the legal and public
Carey School of Law and the
health issues associated with
Professors Mathew Swinburne and Kathleen Hoke
Network for Public Health
cannabis. He regularly meets
Law have been at the forefront
with health departments, health
of addressing these complicated
care providers, hospitals, business
conduct research related to medical
challenges to ensure a safe, efficient,
cannabis. Clinic student Kevin Redden and professional associations, law
and equitable medical cannabis system. ’20 testified in support of a Senate
enforcement, and government officials
to provide guidance on a myriad of
bill that would have prohibited the
The Public Health Law Clinic,
legal challenges. The broad spectrum
revocation of parole based on use or
directed by Professor Kathleen Hoke,
of concerns he hears about include
possession of cannabis for qualified
has been involved in Maryland’s
illegal youth access, employment drug
patients and licensed individuals
medical cannabis program since its
testing, medical cannabis use in public
in the cannabis industry. Redden
inception. The clinic has played a key
testified that punishing parolees who
housing, product safety, and over-therole in educating Maryland’s public
counter sales of CBD products.
are certified patients or licensees
health community by tracking and
within the state-created medical
reporting on cannabis legislation every cannabis industry subverts the goals
Given the outpouring of interest
session. In addition, under Professor
in legal issues raised by the state’s
of the medical cannabis program and
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The Public Health Law Clinic and Network for Public
Health Law Continue to Influence State Policy on
Cannabis Regulation, cont.
medical cannabis program, the
law school, the Network, and the
Maryland Commission on Civil
Rights co-sponsored a conference
at Maryland Carey Law this past
May. The conference focused on the
evolving legal landscape for medical
cannabis at the federal and state level,
the science of medical cannabis, and
issues of employment and housing
law that impact employees and
tenants who use medical marijuana.
As a result of this conference and
the network’s recognized expertise,
Hoke and Swinburne were invited
to be part of the Maryland Medical
Cannabis Commission’s workgroup
that is developing regulations for
Maryland’s newly legalized edible
cannabis products (e.g. cannabis

infused cookies and candies). Edible
cannabis products create unique
public health challenges including
their attractiveness to children, food
safety concerns, and potential dosing
problems. The Maryland Medical
Cannabis Commission also posted
draft regulations on edibles, which are
available at http://bit.ly/2kp05Se.

and to make recommendations for
potential legislation in 2020. Again,
the legislature reached out for the
network’s expertise. Swinburne
conducted multiple presentations for
the work group on federal regulation
of cannabis and the variety of state
approaches to regulating recreational
cannabis use.

Regulation of cannabis continues to
advance in Maryland at a blistering
pace. Several bills were introduced
this past session to legalize
recreational cannabis in Maryland, all
of which died in committee. However,
the General Assembly created a
bipartisan workgroup of senators and
delegates to study the implications
of a recreational cannabis system

As the cannabis industry continues to
grow and the laws regulating it evolve,
the University of Maryland Francis
King Carey School of Law and the
Network for Public Health Law will
continue to be a critical resource at the
vanguard of this field. ■

School of Pharmacy Offers MS
in Medical Cannabis
The University of Maryland, Baltimore (UMB)
continues to lead the field of medical marijuana
through initiatives in its other professional schools.
The School of Pharmacy recently launched a new
and unique Master of Science (MS) in Medical
Cannabis Science and Therapeutics to provide
students with the knowledge and skills needed
to support patients and the medical cannabis
industry, add to existing research in the field, and
develop well-informed medical cannabis policy. The
MS in Medical Cannabis Science and Therapeutics
is the first graduate program in the country
dedicated to the study of medical cannabis. It
aims to meet the needs of all individuals interested
in advancing their knowledge about medical
cannabis, including health care professionals such
as physicians, nurses, and pharmacists; scientists
and regulators; growers and dispensary owners;
and policy and industry professionals.
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“Medical cannabis has been legalized in 33 states,
including Maryland, as well as in Washington,
D.C., Guam, and Puerto Rico,” says Natalie D.
Eddington, dean and professor of the School
of Pharmacy. “This number is only expected to
increase in the future, fueling a demand for an
educated workforce that is well-trained in both the
science and therapeutic effects associated with this
medicinal plant.
Graduates of the program will be able to help
identify patients appropriate for medical cannabis
therapy and determine appropriate dosing and
administration for those patients; ensure the
safe and effective design, development, and
manufacture of medical cannabis products; identify
potential research opportunities related to the
science and health effects of the cannabinoids
found in medical cannabis; and participate in
health policy decision-making processes related to
medical cannabis. Coursework will include a class
on federal and state cannabis laws and policies. ■

Health Law Faculty in the News
Rena Steinzor

Natalie Ram

was quoted in “Customers Handed
Over Their DNA. The Company Let the
FBI Take a Look” in The Wall Street
Journal on August 22.
“Taking a DNA test does not just tell a
story about me. DNA tests inevitably reveal
information about many other people
too, without their consent,” says Natalie
Ram, an associate professor of law at
the University of Maryland Francis King
Carey School of Law, who studies genetic
privacy. “Should genetic databases be
allowed to make up the rules as they go
along?” … Ms. Ram, of the University of
Maryland, thinks consumers should be
required to take affirmative steps to opt in
to law-enforcement matching, rather than
having to decide to take steps to opt out.”

was quoted in Propublica’s “The Car Seat
Industry Helped Delay a Child Safety
Regulation — Again” on August 20.
“Consumer advocates have raised concerns
about the delays. ‘I don’t understand why
anyone hasn’t sued,’ said Rena Steinzor,
a professor of administrative law at the
University of Maryland School of Law.
An agency can be sued for unreasonable
delays in implementing regulations or
for failing to meet a deadline specified by
Congress. ‘Unless they are worried that the
Trump [National Highway Traffic Safety
Administration] would come up with a very
weak rule,’ she added.”

Frank Pasquale

was quoted in “Health Data Outside
HIPAA: The Wild West of Unprotected
Personal Data” in The Health Care Blog
on August 12.

“Quoted in the NCVHS report, Law
Professor Frank Pasquale concluded
that for health data outside the
healthcare sector, ‘in many respects, it is
anything goes.’”

Kathleen Hoke
was quoted in Mother Jones’ “Juuls Campaign to Raise the Tobacco Age is More
Complicated than it Seems” on August 22.
“Though legislation to raise the legal age for tobacco consumption to 21 may sound like a
move to protect youth from harmful health effects, experts say it’s more complicated than that.
‘We see that they want to put this out there to make it look like they’re the good guy,’ Hoke says.
‘But they’re not really trying. They don’t expect it to really hurt their business.’ The legislation
would have a ‘negligible’ impact on smoking, she says. Without dedicated enforcement—which
fluctuates with state budgets and is complicated by the internet marketplace—raising the age
limit may not do much. Raising the age to 21… could prohibit local governments from passing
measures that could also alter teen use, like banning flavored tobacco.”
Law & Health Care Program
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2019 Health Law Certificate Graduates
Celebrated at Annual Reception

A

t the 2019 Reception for Health
Law Certificate Graduates, held
at Westminster Hall on May 17, the
Law & Health Care Program, along
with many members of its more
than 20 full time faculty and adjunct
instructors, celebrated the successes
of each of the 25 exemplary health
law certificate students. This was
the 22nd year that the Law & Health
Care Program awarded Health Law
Certificates to students who completed
the concentration in health law, which
requires that the students take 17 of
their 85 law school credits in health
law, participate in a health law clinic
or externship, and write a scholarly
paper on a health law topic. Most of
the students went well beyond the
minimum health law credits and
engaged in numerous and varied
externships and activities, which

made the L&HCP class of 2019 a
wonderfully rich and active group of
students.
Many certificate recipients showed
outstanding leadership throughout
their law school careers, including
at the helm of the Journal of Health
Care Law and Policy, which serves
as a forum for the interdisciplinary
discussion of leading issues in health
law, medicine, and health policy, and
the Student Health Law Organization,
which does a wonderful job of
developing events and opportunities
for students. Other health law students
represented the law school proudly in
the national health law competitions,
including fielding a strong team
in Maryland Carey Law’s Health
Law Regulatory and Compliance
Competition. These are just a few of

the impressive endeavors undertaken
by this special group of students.
Health law students often come to the
program with impressive academic
credentials from other prestigious
institutions. Many of this year’s
graduates have advanced degrees,
including master’s or doctoral degrees
in Pharmacy, Public Health, and
Business Administration. Certificate
recipients will go on to work in a
variety of impressive jobs, including
in large law firms, federal agencies,
and judicial clerkships, but every
recipient graduates well prepared for a
successful, rewarding career in health
law and policy. Below, we highlight
just a few of our exceptional 2019
graduates and their achievements.

2019 Health Law Certificate Recipients
Iyah Chen
Ashley Creech
Laura Daube
Lysette Alicia Deshields
Tessa Devereaux
Jaclyn Fonteyne
Moyosore Olayimika Koya

Yuezhu Liu
Wenjia Ma
Laura Macherelli
Harriyah Narnor
Ariel Neumann
Raynna Nkwanyuo
Ezinne Onwuegbu

Alec Prechtel
Reza Sadeghi
Timothy P. Scott, Jr.
Kiamesha Diamond Stewart
Adrienne Westcott Thomas
John Travers
Payal Ved

Hansi Wei
Sarah Wicks
Ellis Zapas
Vanessa Zehnder

Ashley Creech
Ashley Creech was a keen student of health law and leader on campus and beyond.
Ashley was an outstanding leader for the Journal of Health Care Law and Policy as
its editor-in-chief. She inspired the entire board and group of editors to carefully and
expertly prepare articles for publication, and together, they ensured that the journal
remains an impressive venue for serious research. Ashley also mentored a very busy and
high-achieving group of students, and her work leading the journal received the highest
praise from faculty leaders. According to Professor Frank Pasquale, faculty advisor for
the Journal of Health Care Law and Policy, who had Ashley in his class, Ashley is also
Professor Karen Rothenberg, Ashley Creech, and
an extraordinarily conscientious and thoughtful student. Ashley writes compellingly
Professor Diane Hoffmann
and her work is very carefully considered. In the classroom, Ashley dedicated herself to
mastering the material, especially in the very comprehensive and challenging Health Care Law and Policy course. Professor Pasquale
also described her as “terrific” and “involved in the law school community and beyond,” stating that Ashley “will be an excellent
counselor to both business and government leaders.” Ashley will begin her legal career at Epstein, Becker & Green, P.C.
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Lysette Deshields
Lysette Deshields came to the law school already having another professional degree,
a Doctor of Pharmacy. And, already having a full-time job at the Food and Drug
Administration (FDA) as a regulatory officer, Lysette came to Maryland as an evening
student. She is also a lieutenant commander in the U.S. Public Health Service. Professor
Diane Hoffmann met Lysette in the spring of 2017 when she was a student in Hoffmann’s
Critical Issues in Health Care course, a multidisciplinary course that includes law,
medicine, nursing, pharmacy, social work, graduate public health and sometimes dental
students. Hoffmann remembers that “although she was quiet in the class, Lysette ended
Lysette Deshields and Professor Diane Hoffmann
up with the highest grade of any law student.” Lysette’s law school work showed that
in addition to the analytical skills she honed in pharmacy and law school, Lysette is
a compassionate person who cares about others and is family oriented. Her outside experience includes having delivered patient
counseling and drug utilization review for patients during a Haiti Medical Mission. Hoffmann remarked that Lysette’s “combination of
analytical skills and compassion for others will serve her well as she pursues a career that takes advantage of her background as both a
pharmacist and now a lawyer.” Lysette will put these skills to good use as she continues her career at the FDA’s Office of Compliance.

Jaclyn Fonteyne
Jaclyn Fonteyne has been described by her clinical supervisor, Professor Kathleen Hoke,
as having a “larger than life presence in the Public Health Law Clinic.” Her success in the
clinic and beyond can be attributed not only to her positive attitude, but also to her ability
to receive advice and turn in a final work product that reflected her strong researching
and writing skills as well as her ability to listen to and incorporate feedback. Jaclyn has a
special interest in food and drug law, which she put to good use as a Public Health Law
Clinic student. One of the projects Jaclyn worked on during her time in the clinic was
testimony before the Maryland House and Senate on a bill that will take effect this fall
Professor Kathleen Hoke, Jaclyn Fonteyne, and
making 21 the new minimum age for purchasing tobacco products in the state. According
Professor Diane Hoffmann
to Hoke, “Jaclyn was poised and engaging during her testimony, but her substantive
contributions to the bill behind the scenes were just as valuable.” In addition to her clinical work, Jaclyn was involved in many other
student organizations and activities, including as an editor of the Maryland Law Review, peer advisor, teaching fellow, and member of
the Alternative Dispute Resolution Team and the Student Health Law Organization. Among her other attributes, Jaclyn is also fluent
in both French and German, having worked for a pharmaceutical company in Germany prior to law school. Jaclyn started in the Food,
Drug, and Medical Device Regulatory Practice of Sidley Austin LLP’s Washington, D.C. office this fall.

Sarah Wicks
Sarah Wicks began her legal career at Hyman, Phelps & McNamara, P.C. this fall, where
she is serving clients in the pharmaceutical and biotechnology industry using her strong
knowledge of regulations and intellectual property transactions. Her law school record
clearly shows her devotion to mastering those subject areas. During law school, Sarah
served as a research assistant for faculty members and the Mississippi Center for Justice,
a student attorney in the Intellectual Property Clinic, and a healthcare consulting firm
intern at the United States Court of Federal Claims, the FDA, and a major pharmaceutical
company, to name just a few of her many valuable experiences. During law school, she
Professor Leslie Meltzer Henry, Sarah Wicks, and
also earned her master’s degree in Public Health from the Johns Hopkins Bloomberg
Professor Diane Hoffmann
School of Public Health. She was a member of the Journal of Health Care Law and
Policy, the Maryland Intellectual Property Student Association, and the Student Health Law Organization, and she co-authored a paper
published in April in the International Journal of Pharmaceutics. There is no doubt that Sarah will excel in the legal profession, just as
she did at Maryland. ■
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9th Annual Health Law Regulatory and Compliance Competition
The Health Law Regulatory and Compliance Competition is a unique and innovative competition that
challenges students to navigate through the complex regulatory landscape of health care law, including
compliance with health care regulations and FDA law. The competition will be held on Saturday, February
22, 2019, from 8:00 a.m. until 3:00 p.m. at the University of Maryland Francis King Carey School of Law in
Baltimore, Maryland.

About the Competition

The competition requires teams of 2-3 students to analyze a hypothetical fact pattern involving various
interactions between health care stakeholders and entities participating in several health care activities
that necessitate regulatory and compliance oversight. The fact pattern will be given to teams the day of
the completion, and students will have approximately 1.5 hours to analyze the problem. Teams will then
present their findings and recommendations to a panel of practicing regulatory and compliance attorneys.
The 9th annual competition will focus on several interactions between various health care stakeholders,
including hospitals, physicians, drug and device manufacturers and related third parties.

Call to Compete

If you would like to have a team from your law school participate in the competition, you can find
additional details and information about how to register at https://www.law.umaryland.edu/Programsand-Impact/Health-Law/HLRCC/.

